Beigene Ltd ADR (NQ: BGNE )
207.99
-1.32
(-0.63%)
Streaming Delayed Price
Updated: 12:08 PM EDT, Sep 25, 2024
Add to My Watchlist
Press Releases about Beigene Ltd ADR
From BeiGene
Via Business Wire
From BeiGene
Via Business Wire
From BeiGene
Via Business Wire
Via GlobeNewswire
Via GlobeNewswire
From BeiGene
Via Business Wire
From BeiGene
Via Business Wire
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023
From BeiGene, Ltd.
Via Business Wire
BeiGene Receives 10th Approval for PD-1 Inhibitor Tislelizumab in China
February 24, 2023
From BeiGene
Via Business Wire
BeiGene to Present at Cowen’s 43rd Annual Healthcare Conference
February 24, 2023
From BeiGene
Via Business Wire
BeiGene to Present at Upcoming Investor Conferences
February 01, 2023
From BeiGene
Via Business Wire
BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia
January 19, 2023
From BeiGene
Via Business Wire
BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug List
January 18, 2023
From BeiGene
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.